The heart in scleroderma

Area of Science:

• Cardiology
• Rheumatology
• Internal Medicine

Background:

• Scleroderma is a systemic autoimmune disease with significant cardiac involvement.
• Cardiac manifestations include myocardial disease, conduction abnormalities, arrhythmias, and pericardial disease.
• Kidney and lung complications (scleroderma renal crisis, pulmonary hypertension) exacerbate cardiac dysfunction.

Purpose of the Study:

• To summarize the types and mechanisms of cardiac abnormalities in scleroderma.
• To highlight the growing interest in cardiac dysfunction in scleroderma and related rheumatologic conditions.
• To emphasize the need for long-term studies in managing cardiac manifestations.

Main Methods:

• Review of existing literature on cardiac involvement in scleroderma.
• Discussion of mechanisms underlying cardiac dysfunction.
• Consideration of advancements in noninvasive imaging techniques.

Main Results:

• Scleroderma can directly impact heart muscle, electrical conduction, and the pericardium.
• Secondary cardiac dysfunction is a significant concern due to renal and pulmonary complications.
• Subclinical cardiac disease detection is improving with new imaging technologies.

Conclusions:

• Cardiac abnormalities are a major feature of scleroderma, impacting multiple heart components.
• Understanding the mechanisms of cardiac dysfunction is crucial for patient management.
• Further long-term research is essential to optimize screening protocols and therapeutic strategies for cardiac manifestations in scleroderma.